Zusammenfassung
Fast 25% aller bei Männern neu diagnostizierten Malignome nehmen ihren Ursprung von den ableitenden Harnwegen oder den männlichen Geschlechtsorganen. In der westlichen Welt ist das Prostatakarzinom der häufigste Tumor des Mannes, das Blasenkarzinom folgt an 5. Stelle.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Altwein J, Ekman P, Barry M et al. (1997) How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium. Urology 49 (Suppl 4A): 6676
Bratt O, Nilsson T, Stenzelius K (2002) Palliative cancer care is an important part of urology. A study of the last year of life of patients who dies because of urologic cancer. Lakartidningen 99/8: 765–767, 770
Dawson N (2002) Bisphosphonates: their evolving role in the management of prostate cancer-related bone disease. Curr Opin Urol 12: 413–418
Eisenberger M, Carducci M (2002) Chemotherapy for hormone-resistant prostate cancer. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds) Campbell’s urology, vol 4. Saunders, Philadelphia, pp 3209–3226
Kalman D, Varenhorst E (1999) The role of arterial embolization in renal cell carcinoma. Scand J Urol Nephrol 33/3: 162170
Otto T, Krege S (1999) Aktuelle Aspekte in der operativen Ther- apie des Harnblasenkarzinoms. Urologe [B] 39: 310–312
Picus J, Schultz M (1999) Docetaxel (Taxotere) as a monotherapy in the treatment of hormone-refractory prostate cancer: preliminary results. Semin Oncol 26/5 (Suppl 17 ): 14–18
Russo P (2000) Urologic emergencies in the cancer patient. Semin Oncol 27 /3: 284–298
Schröder FH (2002) Hormonal therapy of prostate cancer. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds) Campbell’s urology, vol 4. Saunders, Philadelphia, pp 3182–3208
Westney OL, Pisters LL, Pettaway CA et al. (1998) Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomyfortransitional cell carcinoma of the bladder. J Urol 159 /3: 792–795
Zola P, Maggino T, Sacco M et al. (2000) Prospective multicenter study on urologic complications after radical surgery with or without radiotherapy in the treatment of IB-IIA cervical cancer. Int J Gynecol Cancer 10 /1: 59–66
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Röntgen, R. (2004). Urologie. In: Hankemeier, U.B., Krizanits, F.H., Schüle-Hein, K. (eds) Tumorschmerztherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18939-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-18939-5_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62366-0
Online ISBN: 978-3-642-18939-5
eBook Packages: Springer Book Archive